Feasibility of CALM in Patients With Ovarian Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Managing Cancer And Living Meaningfully (CALM).
- Who it may be relevant to
- Registry conditions: Patient Satisfaction, Ovarian Cancer. Basic parameters: from 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
A Feasibility Trial of Managing Cancer and Living Meaningfully (CALM) in Patients With Newly Diagnosed and Recurrent Advanced Ovarian Cancer
Overview
The goal of this feasibility trial is to determine the feasibility and acceptability of implementing a brief evidence-based psychotherapeutic intervention, Managing Cancer And Living Meaningfully (CALM), at the time of a new diagnosis and recurrence of ovarian cancer (OC). The main questions are: 1. Is it feasible and acceptable to implement CALM for patients with newly diagnosed or recently recurred advanced OC 2. What are the prevalence and correlates of traumatic stress symptoms at baseline in patients with newly diagnosed or recently recurred advanced OC Participants will be asked to complete questionnaires at baseline and at 3 and 6 months following a diagnosis or recurrence of stage III or IV OC. Participants will also be invited to participate in 3-6 sessions of CALM therapy.
Detailed description
While CALM has demonstrated effectiveness in reducing depression, death anxiety and increasing preparation for end of life among patients with advanced cancer later in the illness trajectory, its feasibility and effectiveness in addressing traumatic stress symptoms (TSS) soon after a diagnosis of advanced cancer has not previously been established. Findings of this study could inform the potential development of a larger randomized effectiveness trial. This study will involve a multi-method, single-arm, feasibility trial, approaching a total of 100 OC patients (50 newly diagnosed and 50 recently recurred) at Princess Margaret Cancer Centre (PM). Measurements will be administered at baseline, 3 months and 6 months. Participants who declined to participate in the intervention will be invited to share their reasons for opting out, contributing valuable insights to our records. A subset of purposefully sampled participants will also complete qualitative interviews following the completion of outcome measures at 6 months.
Interventions
- Other Managing Cancer And Living Meaningfully (CALM)
Our team has developed a brief, manualized, individual and couple-based psychotherapeutic intervention for patients living with advanced cancer and their primary caregivers called Managing Cancer and Living Meaningfully (CALM). CALM is a brief supportive-expressive therapy consisting of 3-6 sessions of 30-60 minutes delivered over the course of 3-6 months. This tailored therapy is focused on the most common challenges and concerns facing individuals living with advanced cancer. These four broad
Primary outcome measures
- Stanford Acute Stress Reaction Questionnaire (SASRQ) [Time frame: This questionnaire will be administered at all timepoints (baseline, 3 months and 6 months)]
- Clinical Evaluation Questionnaire (CEQ)-CALM [Time frame: This questionnaire will be administered at 3 months and 6 months only.]
Secondary outcome measures (4)
- Modified Experiences in Close Relationships (ECR-M-16) [Time frame: This questionnaire will be administered at baseline.]
- Condensed Memorial Symptom Assessment Scale (CMSAS) [Time frame: This questionnaire will be administered at all timepoints (baseline, 3 months and 6 months).]
- Patient Health Questionnaire (PHQ-9) [Time frame: This questionnaire will be administered at all timepoints (baseline, 3 months and 6 months).]
- Death and Dying Distress Scale (DADDS) [Time frame: This questionnaire will be administered at all timepoints (baseline, 3 months and 6 months).]
Eligibility criteria
Inclusion criteria
- new diagnosis or recurrence of stage III or stage IV OC;
- age ≥18 years
- able to complete outcome measures and engage in CALM in English.
Exclusion criteria
- evidence of cognitive impairment indicated in the medical record, communicated by the OC clinic team, or determined by research staff at recruitment;
- receiving psychological or psychiatric counseling from the Department of Supportive Care at PM at the time of recruitment.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
Canada · 1 center
- Princess Margaret Cancer Centre — Toronto
Identifiers
NCT: NCT06459271 · 23-5885